Clinical trials
Phase 1 Esophageal Neoplasms trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 6 |
| Completed | 5 |
| Recruiting | 3 |
| Terminated | 3 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 2 |
| Pfizer | 2 |
| USWM CT, LLC | 2 |
| AbbVie | 1 |
| Bristol-Myers Squibb | 1 |
| Centre hospitalier de l'Université de Montréal (CHUM) | 1 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| Eli Lilly and Company | 1 |
| Genentech, Inc. | 1 |
| POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Esophageal Neoplasms | 18 |
| Stomach Neoplasms | 10 |
| Carcinoma, Non-Small-Cell Lung | 9 |
| Colorectal Neoplasms | 8 |
| Melanoma | 7 |
| Ovarian Neoplasms | 6 |
| Squamous Cell Carcinoma of Head and Neck | 6 |
| Neoplasm Metastasis | 5 |
| Endometrial Neoplasms | 4 |
| Head and Neck Neoplasms | 4 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.